Singapore Immunology Network (SIgN)
A comprehensive ranking of 14 algorithms may help bioinformaticians overcome inconsistencies during data collection.
A multifaceted study by the Singapore 2019 Novel Coronavirus Outbreak Research team is filling in some of the gaps left in the urgent quest to understand COVID-19 infection.
A*STAR researchers identify new, specific markers of severe COVID-19 that may improve the management and treatment of patients.
New clues into how the immune system remembers a dengue infection may lead to a better vaccine.
Serology testing may be fast and easy to perform, but there are still some limitations that need to be overcome, suggests Laurent Renia.
Clinicians and scientists have discovered a rare mutation that impairs the immune system, and are using their findings to devise treatment strategies
The presence of memory T cells in COVID-19-recovered patients hints at their importance in COVID-19 immunity.
Could there be a drug that can both treat and protect against COVID-19? The answer may be found in antibody drugs, a promising therapeutic modality against the coronavirus.
A novel targeting strategy may make pave the way for effective cancer immunotherapy against previously ‘undruggable’ targets.
Two coronavirus experts suggest that the best way to control an outbreak may be to first understand viral biology and behavior in animals and humans.
Scientists at A*STAR have found that a mutation in SARS-CoV-2 called ∆382 leads to milder clinical outcomes, with implications for COVID-19 treatments and vaccines.